| Old Articles: <Older 831-840 Newer> |
 |
D-Lib Sep/Oct 2012 Manghi et al. |
OpenAIREplus: the European Scholarly Communication Data Infrastructure This paper describes the high-level architecture and functionalities of the Open Access European scholarly communication data infrastructure.  |
Pharmaceutical Executive September 1, 2012 |
Patients Wade Into the Pricing Debate Europe's fiscal crisis is becoming a new rallying cry for patient groups, but regional unity is still elusive.  |
AskMen.com September 9, 2012 Loukas Mexis |
Moving Back In With Parents The economic difficulties that devastated Greek households are forcing more and more 30-year-olds to return to their parent's household with a terrible sense of defeat.  |
Chemistry World September 7, 2012 |
Food with a function Compounds normally thought of as medicines are being added to food. Elinor Hughes looks at the scientific and regulatory challenges facing these nutraceuticals.  |
Chemistry World August 28, 2012 Andrew Turley |
Myelofibrosis drug approved in EU Jakavi (ruxolitinib) tablets have been approved in the EU for the treatment of myelofibrosis, a rare disease affecting the bone marrow.  |
Chemistry World August 23, 2012 Simon Campbell |
Protecting patients at all costs A new funding model is urgently required to deliver innovative medicines that meet the medical needs of the 21st century and contribute to economic growth.  |
Chemistry World August 7, 2012 Laura Howes |
European air pollution concerns The European Environment Agency has reported that 11 of the member states of the European Union have exceeded the emission limits set by the Convention on long-range transboundary air pollution.  |
CFO August 1, 2012 Andrew Sawers |
Euro Slide Sparks M&A Interest The weakening currency makes European assets more attractive.  |
Chemistry World July 30, 2012 Ned Stafford |
Bleak outlook for Greek chemistry The chemistry community in Greece has not escaped the financial storms that have battered the Greek economy over the past two years. The damage to the chemical sciences and academia is already severe and the future looks bleak.  |
Chemistry World July 25, 2012 |
Drugs Top EU Counterfeit Imports In 2011, EU customs officers stopped 115 million products suspected of violating intellectual property rights. Medicines top the list, accounting for 24% of those items.  |
| <Older 831-840 Newer> Return to current articles. |